This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Karo Pharma Bilan de santé
Santé financière contrôle des critères 1/6
Informations clés
104.8%
Ratio d'endettement
SEK 8.65b
Dette
| Ratio de couverture des intérêts | 0.2x |
| Argent liquide | SEK 353.10m |
| Fonds propres | SEK 8.26b |
| Total du passif | SEK 10.24b |
| Total des actifs | SEK 18.49b |
Mises à jour récentes de la santé financière
Recent updates
Analyse de la situation financière
Passif à court terme: KA6N's short term assets (SEK1.7B) exceed its short term liabilities (SEK626.0M).
Passif à long terme: KA6N's short term assets (SEK1.7B) do not cover its long term liabilities (SEK9.6B).
Historique et analyse du ratio d'endettement
Niveau d'endettement: KA6N's net debt to equity ratio (100.5%) is considered high.
Réduire la dette: KA6N's debt to equity ratio has increased from 59.5% to 104.8% over the past 5 years.
Couverture de la dette: KA6N's debt is not well covered by operating cash flow (5.9%).
Couverture des intérêts: KA6N's interest payments on its debt are not well covered by EBIT (0.2x coverage).